$1.25 stock on next positive SAS results (de-risks clinical trial further), $2-$2.50 on Phase II trial success, $5-10 on licensing deal. On the flipside, cash backing of $0.05 on Phase II failure.
Downside only limited to what I'm willing to lose, upside will pay for a nice little vacation home. I'll take those odds any day. Not taking a single share out of my holdings until the outcome is final. Will be a fruitful ride (I hope). All IMO.
FA bagger potential, page-51
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $71.79M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 19.5¢ | $203.7K | 1.013M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21749 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 24639 | 2 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |